M K Proteins Limited (IN:MKPL)
:MKPL
Want to see IN:MKPL full AI Analyst Report?
Top Page
M K Proteins Limited
(MKPL)
Select Model
Select Model
Rating:59Neutral
Price Target:
₹5.50
▼(-20.17% Downside)
Action:ReiteratedDate:04/07/26
The score is primarily driven by mixed financial performance: solid profitability and ROE are offset by unstable revenue trends, negative operating/free cash flow, and higher leverage risk. Technicals are neutral-to-cautious with a short-term rebound but weaker longer-term trend signals, while valuation is pressured by a high P/E and no dividend yield support.
Positive Factors
Healthy Gross Margin / Profitability
Sustained healthy gross margins indicate effective cost management in refining operations and provide structural buffer against input cost swings. Over the next 2-6 months, this supports margin maintenance and ability to fund operating needs even if sales fluctuate.
Negative Factors
Negative Operating and Free Cash Flow
Persistent negative operating and free cash flows indicate cash generation shortfalls versus reported profits, forcing reliance on external financing. Over months this constrains liquidity, limits capex or working capital flexibility, and raises refinancing risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy Gross Margin / Profitability
Sustained healthy gross margins indicate effective cost management in refining operations and provide structural buffer against input cost swings. Over the next 2-6 months, this supports margin maintenance and ability to fund operating needs even if sales fluctuate.
Read all positive factors
M K Proteins Limited (MKPL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹1.99B
Dividend YieldN/A
Average Volume (3M)20.59K
Price to Earnings (P/E)39.8
Beta (1Y)0.90
Revenue Growth72.12%
EPS Growth-25.75%
CountryIN
Employees48
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.04
Shares Outstanding375,372,000
10 Day Avg. Volume17,806
30 Day Avg. Volume20,591
Financial Highlights & Ratios
PEG Ratio-1.07
Price to Book (P/B)3.46
Price to Sales (P/S)0.90
P/FCF Ratio-13.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
M K Proteins Limited Business Overview & Revenue Model
Company Description
M K Proteins Limited (MKPL) is a premier player in the agro-products sector, specializing in the production and export of high-quality protein products derived from various agricultural sources. The company focuses on providing a diverse range of ...
How the Company Makes Money
MKPL generates revenue by refining and selling edible oils, such as mustard oil, soybean oil, and palm oil. The company sources raw materials, including oilseeds and crude oil, which are then processed at its facilities into finished products. The...
M K Proteins Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.25B | 2.68B | 2.46B | 3.15B | 2.56B | 3.11B |
| Gross Profit | 196.86M | 156.53M | 192.91M | 204.93M | 186.78M | 186.15M |
| EBITDA | 146.78M | 129.08M | 170.99M | 176.52M | 157.88M | 159.81M |
| Net Income | 94.29M | 83.97M | 112.12M | 109.35M | 101.84M | 103.89M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 1.31B | 962.46M | 1.03B | 861.48M | 673.53M |
| Cash, Cash Equivalents and Short-Term Investments | 338.00K | 338.00K | 923.24K | 624.84K | 66.62K | 12.56K |
| Total Debt | 0.00 | 387.24M | 200.83M | 455.35M | 367.84M | 251.29M |
| Total Liabilities | -694.66M | 611.04M | 351.70M | 533.55M | 465.44M | 380.15M |
| Stockholders Equity | 694.66M | 694.66M | 610.76M | 498.64M | 396.04M | 293.38M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -183.51M | 265.13M | -58.80M | -116.95M | 52.77M |
| Operating Cash Flow | 0.00 | -161.28M | 324.16M | -58.73M | -101.22M | 55.36M |
| Investing Cash Flow | 0.00 | -14.82M | -58.78M | 133.85K | -15.28M | -2.11M |
| Financing Cash Flow | 0.00 | 175.52M | -265.08M | 59.15M | 116.56M | -54.38M |
M K Proteins Limited Technical Analysis
Positive
6.89
Price Trends
5.06
Positive
5.51
Negative
6.23
Negative
Market Momentum
0.08
Negative
55.42
Neutral
48.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MKPL, the sentiment is Positive. The current price of 6.89 is above the 20-day moving average (MA) of 4.93, above the 50-day MA of 5.06, and above the 200-day MA of 6.23, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 55.42 is Neutral, neither overbought nor oversold. The STOCH value of 48.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MKPL.
M K Proteins Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹2.03B | 3.78 | ― | ― | 7.69% | 55.78% | |
68 Neutral | ₹12.79B | 11.48 | ― | 1.06% | 19.27% | 86.29% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹1.99B | 39.81 | ― | ― | 72.12% | -25.75% | |
48 Neutral | ₹414.03M | -2.42 | ― | ― | ― | ― | |
46 Neutral | ₹45.56B | 39.15 | ― | ― | -9.36% | 67.67% | |
46 Neutral | ₹286.52M | -0.44 | ― | ― | 1363.04% | -123.16% |
* Consumer Defensive Sector Average
IN:MKPL
M K Proteins Limited
5.33
-1.29
-19.49%
IN:ANDHRSUGAR
Andhra Sugars Limited
98.82
29.11
41.76%
IN:BAJAJHIND
Bajaj Hindusthan Sugar Limited
19.51
-0.75
-3.70%
IN:DHARSUGAR
Dharani Sugars & Chemicals Ltd.
―
―
―
IN:RANASUG
Rana Sugars Limited
13.45
-0.47
-3.38%
IN:SIMBHALS
Simbhaoli Sugars Ltd
10.03
-3.95
-28.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.